View item

US Department of Defense – Tuberous Sclerosis Complex Research Program (TSCRP) – Clinical Translational Research Award
Sponsor: US Department of Defense 		Closing Date: 11-Jul-2018
The Clinical Translational Research Award supports forward and/or reverse clinical/translational studies that have a reciprocal flow of ideas and information between basic and clinical science and have the potential to improve the diagnosis, prognosis, or treatment of TSC. Projects supported by this award mechanism may include studies moving from preclinical to clinical research (including a pilot clinical trial) and/or the reverse, analyzing human anatomical substances and/or data associated with clinical trials (such as correlative studies) to develop models that recapitulate relevant clinical outcomes for use in translational research.

Eligibility
• Independent Investigators at or above the level of Assistant Professor (or equivalent) are eligible to apply.

Key Mechanism Elements
• Supports forward and/or reverse clinical/translational studies that have the potential to improve the diagnosis, prognosis, or treatment of TSC.
• Preference will be given to studies that involve human samples, patients, or leverage existing clinical data and/or ongoing clinical studies.
• Preclinical studies may be appropriate but must include a clinical component.
• Applications may include a small, pilot clinical trial intended to inform the next step in the continuum of translational research.
• Should provide evidence for the reciprocal transfer of information between basic and clinical science.
• Preliminary data required.

Funding
• Maximum funding of USD $600,000 for direct costs. Indirect costs may be proposed in accordance with the institution’s negotiated rate agreement.
• Maximum period of performance is 3 years.

Please see the U.S. Department of Defense Congressionally Directed Medical Research Program (CDMRP) website at http://cdmrp.army.mil/funding/tscrp and http://cdmrp.army.mil/tscrp/default for further information. Pre-applications are submitted via the CDMRP’s Electronic Biomedical Research Application Portal (EBRAP) and full applications are submitted via Grants.gov. For complete instructions for pre-applications and full applications, you must refer to both the Program Announcement and General Application Instructions documents.

Key Dates
Full applications due to UQR&I: 4 July 2018
Pre-applications (mandatory) close with US Department of Defense: 11 July 2018
Full applications close with US Department of Defense: 2 August 2018

Ahead of internal review, ensure all online components on EBRAP or Grants.gov are complete. To initiate review, email your completed Funding Application Coversheet to internationalgrants@research.uq.edu.au. Interested applicants are strongly encouraged to make contact with the UQR&I international team (internationalgrants@research.uq.edu.au) well in advance of the UQR&I internal deadline to discuss their application.
Website: http://cdmrp.army.mil/funding/tscrp

Return